Irreversible Inactivation of Trypanothione Reductase by Unsaturated Mannich Bases:  A Divinyl Ketone as Key Intermediate

Journal of Medicinal Chemistry
2005.0

Abstract

Trypanothione reductase is a flavoenzyme unique to trypanosomatid parasites. Here we show that unsaturated Mannich bases irreversibly inactivate trypanothione reductase from Trypanosoma cruzi, the causative agent of Chagas' disease. The inhibitory potency of the compounds strongly increased upon storage of the DMSO stock solutions. HPLC, NMR, and mass spectrometry data of potential intermediates revealed a divinyl ketone as the active compound inactivating the enzyme. ESI- and MALDI-TOF mass spectrometry of trypanothione reductase modified by the Mannich base or the divinyl ketone showed specific alkylation of the active site Cys52 by a 5-(2'chlorophenyl)-3-oxo-4-pentenyl substituent. The reaction mechanism and the site of alkylation differ from those in Plasmodium falciparum thioredoxin reductase where the C-terminal redox active dithiol is modified. After deamination, unsaturated Mannich bases are highly reactive in polycondensation with trypanothione. Interaction of these compounds with both trypanothione and trypanothione reductase could account for their potent trypanocidal effect against Trypanosoma brucei.

Knowledge Graph

Similar Paper

Irreversible Inactivation of Trypanothione Reductase by Unsaturated Mannich Bases:  A Divinyl Ketone as Key Intermediate
Journal of Medicinal Chemistry 2005.0
Inhibitors ofTrypanosoma cruziTrypanothione Reductase Revealed by Virtual Screening and Parallel Synthesis
Journal of Medicinal Chemistry 2005.0
The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
Bioorganic & Medicinal Chemistry 2008.0
Inhibition of Trypanosoma cruzi Trypanothione Reductase by Acridines:  Kinetic Studies and Structure−Activity Relationships
Journal of Medicinal Chemistry 1999.0
Novel polyamine derivatives as potent competitive inhibitors of Trypanosoma cruzi trypanothione reductase
Bioorganic & Medicinal Chemistry Letters 1995.0
Phenothiazine Inhibitors of Trypanothione Reductase as Potential Antitrypanosomal and Antileishmanial Drugs
Journal of Medicinal Chemistry 1998.0
Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei , Trypanosoma cruzi and Leishmania donovani
Bioorganic & Medicinal Chemistry Letters 2000.0
High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity
Bioorganic & Medicinal Chemistry Letters 2007.0
Use of an Additional Hydrophobic Binding Site, the Z Site, in the Rational Drug Design of a New Class of Stronger Trypanothione Reductase Inhibitor, Quaternary Alkylammonium Phenothiazines
Journal of Medicinal Chemistry 2000.0
Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity
European Journal of Medicinal Chemistry 2017.0